Hello,
I'm on approximately day 45 of a trial of aripiprazole (Abilify). I wanted to do a post around day 50 or so, but I am feeling the pressure to post based on the recent Abilify thread. I decided to try Abilify after hearing that Whitney was improving on it.
I have progressive non-HLA-C*07:04, non-HLA-DQB1*03:03 ME/CFS. My main symptoms are fatigue and cognitive and sleep disturbances--PEM is a minor component for me.
Before the trial I would categorize myself as moderate.
Received a prescription for 2mg tablets.
Trial
Day 1-4 took .25 of a tablet or 0.5 mg/day in the morning
Day 5-6 took 0.5 of a tablet of 1 mg/day
Thereafter taking 1 whole 2 mg tablet--still taking it currently
Things started to get better after about a week or so. The main improvement is mornings!
Whereas before I might not get out of bed until 11 AM or so, I now get up and out of bed about 7/8 AM and start doing stuff. It's a pretty dramatic change. More energy overall. So far no poop out or tachyphylaxis (this did occur on valtrex for me). Sleeps seems a bit better.
I think waking up early thing might have to do with findings of this study (sleep offset means waking up).
Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965391/
Results
Sleep onset, midpoint of sleep, and sleep offset were significantly advanced by 1.1, 1.8, and 2.5 hours, respectively. Unexpectedly, sleep duration became significantly shorter by 1.3 hours after treatment. Their depressive moods showed an unremarkable change.
Conclusion
Low dose of APZ advanced the sleep rhythm and reduced nocturnal sleep time in the subjects with DSPS. Since it is not easy for physicians to treat prolonged sleep duration often associated with DSPS, this medication would become a new therapeutic option for these patients.
Overall I'd say I've gone from moderate to mild. I still am not a bundle of energy and still need naps, and still have brain fog, but everything seems to be a lot better. No major side effect either.
If others do trials it probably make sense to collect data and try to publish this (unblinded). Because Abilify is off-patent there will be little incentive do any formal trials. To do a study, will need to find a good questionnaire, e.g. SF-36 physical is not good, Chalder fatigue is not great. Questions like what time do you wake up and what time do you get out of bed would be very useful.
Also, I reached out to Naviaux to ask about mito toxicity from Abilify and here is what he said:
"Yes. This is a well known issue in the mitochondrial medicine community. Atypical antipsychotics have some antimitochondrial effects. .....I am glad that some people with ME/CFS are exepriencing relief with low-dose Abilify. However, I see this as a temporary bandaid that while helping to relieve some symptoms, will not lead to any cures because it is symptomatic treatment and is not directed at the root problem of ME/CFS. Experience teaches us that if any symptomatic treatment is used chronically, a fraction of patients will experience side effects and this fraction will grow in proportion to the duration of treatment."
That's his opinion.